Bellicum Pharmaceuticals, Inc. Gains 102.85%

Mon, Apr 17, 2023 at 07:04 PM
Bellicum Pharmaceuticals, Inc. Gains 102.85%

Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) shot up at $0.57, representing a gain of 102.8%. On Mon, Apr 17, 2023, BLCM:NASDAQ touched a New 2-Week High of $0.57. From Mon, Apr 03, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days

The stock spiked on Mon, Apr 17, 2023 at $1.07 with a volume of 49M+.

About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)

Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.